- Home
- IMVT vs FRPT Comparison
IMVT vs FRPT Comparison
Compare IMVT & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- FRPT
- Stock Information
- Founded
- IMVT 2018
- FRPT 2004
- Country
- IMVT United States
- FRPT United States
- Employees
- IMVT N/A
- FRPT N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- FRPT Packaged Foods
- Sector
- IMVT Health Care
- FRPT Consumer Staples
- Exchange
- IMVT Nasdaq
- FRPT Nasdaq
- Market Cap
- IMVT 2.7B
- FRPT 3.1B
- IPO Year
- IMVT N/A
- FRPT 2014
- Fundamental
- Price
- IMVT $15.53
- FRPT $52.47
- Analyst Decision
- IMVT Buy
- FRPT Buy
- Analyst Count
- IMVT 11
- FRPT 16
- Target Price
- IMVT $33.88
- FRPT $118.80
- AVG Volume (30 Days)
- IMVT 1.6M
- FRPT 1.5M
- Earning Date
- IMVT 11-06-2025
- FRPT 11-03-2025
- Dividend Yield
- IMVT N/A
- FRPT N/A
- EPS Growth
- IMVT N/A
- FRPT 28.97
- EPS
- IMVT N/A
- FRPT 0.66
- Revenue
- IMVT N/A
- FRPT $1,044,013,000.00
- Revenue This Year
- IMVT N/A
- FRPT $16.39
- Revenue Next Year
- IMVT N/A
- FRPT $13.39
- P/E Ratio
- IMVT N/A
- FRPT $79.27
- Revenue Growth
- IMVT N/A
- FRPT 19.30
- 52 Week Low
- IMVT $12.72
- FRPT $52.24
- 52 Week High
- IMVT $32.10
- FRPT $164.07
- Technical
- Relative Strength Index (RSI)
- IMVT 46.91
- FRPT 35.54
- Support Level
- IMVT $16.08
- FRPT $52.70
- Resistance Level
- IMVT $17.20
- FRPT $55.55
- Average True Range (ATR)
- IMVT 0.79
- FRPT 2.23
- MACD
- IMVT 0.09
- FRPT 0.11
- Stochastic Oscillator
- IMVT 36.81
- FRPT 4.87
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.